Craig Tendler

3.6k total citations · 1 hit paper
25 papers, 2.5k citations indexed

About

Craig Tendler is a scholar working on Oncology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Craig Tendler has authored 25 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Dermatology. Recurrent topics in Craig Tendler's work include T-cell and Retrovirus Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Craig Tendler is often cited by papers focused on T-cell and Retrovirus Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Craig Tendler collaborates with scholars based in United States, Poland and Germany. Craig Tendler's co-authors include L. Mellars, Leila Alland, F. Orlandi, Armando Santoro, E O’Brien, Stephen P. Ackland, D G Kieback, Moshe Inbar, Piotr Tomczak and Nely Wigler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Craig Tendler

22 papers receiving 2.5k citations

Hit Papers

Reduced cardiotoxicity and comparable efficacy in a phase... 2004 2026 2011 2018 2004 400 800 1.2k

Peers

Craig Tendler
Comparison fields: 5 of 108
  • Oncology 928
  • Biomaterials 713
  • Immunology 640
  • Biomedical Engineering 531
  • Molecular Biology 509
Replace Kunyu Yang with:
Kunyu Yang China
Martina Rudelius Germany
Patrizio Giacomini Italy
Pauline Verdijk Netherlands
D G Kieback United States
Richard B. Bankert United States
F. Brasseur Belgium
Sonya A. MacParland Canada
Simon Stewart United Kingdom
Dana A. Kennedy United States
Kunyu Yang China View profile →
Citations per field, relative to Craig Tendler
Craig Tendler · 1×
Citations per year, relative to Craig Tendler
Craig Tendler · 1×

Countries citing papers authored by Craig Tendler

Since Specialization
Citations

This map shows the geographic impact of Craig Tendler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Tendler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Tendler more than expected).

Fields of papers citing papers by Craig Tendler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Tendler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Tendler. The network helps show where Craig Tendler may publish in the future.

Co-authorship network of co-authors of Craig Tendler

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Tendler. A scholar is included among the top collaborators of Craig Tendler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Tendler. Craig Tendler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 7
2 1
3 13
4 36
5 2
6
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer breakdown →
1311
7 45
8 118
9 80
10 17
11 35
12 150
13 17
14
Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
40
15 99
16 210
17 5
18 1
19 4
20 7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026